Turn this list into pipeline.
Contract Research Companies in London: 26 Active Firms (2026)
Contract research organisations design, run and report outsourced clinical studies, with London firms serving sponsors under MHRA and GCP oversight.
Buying demand tends to sit with clinical operations, biostatistics, regulatory quality and medical-writing teams rather than being concentrated in procurement. London providers in this field mainly sell to life-sciences sponsors, investigator-led research groups and specialist development teams that need outsourced trial design, monitoring, analysis or reporting capacity. Engagements range from protocol-level support and trial-master-file work to longer managed-service arrangements where the provider takes on operational tasks but the sponsor keeps oversight. The commercial motion is therefore closer to expert services than low-touch software: evidence of GCP controls, documented contracts, escalation routes and audit access matters as much as sector focus.
Read more
London has 26 actively trading contract research firms, making this a narrow specialist cohort inside the UK clinical-research supply chain. Reported employment totals 719 people, so the footprint is visible but remains specialist rather than labour-intensive at London market level. Turnover scale appears uneven: a minority sit above £5M, while others appear closer to advisory, monitoring, statistics or reporting practices. Recent formation is relatively limited, pointing to a market shaped more by existing sponsor relationships and compliance track record than by frequent new entry.
Clinical-trials outsourcing does not remove sponsor accountability. London CROs supporting medicines studies sit under MHRA clinical-trials oversight and Good Clinical Practice expectations, with the same conduct, analysis and reporting standards applying when sponsor or investigator functions are delegated. Serious-breach notification routes, routine or triggered GCP inspections and trial-master-file access are therefore part of the operating model, not after-the-event paperwork. The market structure favours providers that can document contracts, escalation procedures and oversight lines clearly, particularly where a sponsor is using external teams for monitoring, statistics, safety reporting or study close-out.
Future demand appears tied less to broad outsourcing fashion than to whether sponsors can find dependable specialist capacity in a regulated setting. Smaller CROs tend to compete on therapeutic focus, senior trial-operations experience and familiarity with inspection expectations, while mid-market operators have more scope to absorb repeat programmes. Consolidation may remain selective: sponsor accountability makes switching costs real, but it also limits appetite for loosely managed subcontracting networks. The cohort’s early-commercial weight suggests continued churn at the advisory end, with steadier prospects for providers able to evidence oversight discipline without becoming a full-service clinical-services group.
26
Active firms
2026
8
Over £5M revenue
Reported annual revenue
4
New since 2022
Recent incorporations
Key facts
About 30% of the trading cohort reports turnover above £5M (8 of 26 firms) — the rest sits below that revenue band.
15% of the cohort was incorporated since 2022 (4 firms), so a sizeable share is in its first few filing cycles.
MHRA guidance requires contract research organisations that undertake sponsor or investigator functions to comply with Good Clinical Practice.
SI 2004/1031 Regulation 3 keeps responsibility for clinical-trial conduct and reporting with the sponsor when activities are outsourced.
ABPI records 578 industry clinical trials initiated in the UK in 2024, up from 426 in 2023 but below 667 in 2017.
The UK's global share of patients recruited to a subset of commercial trials was 2.6% in 2022, up from 2.2% in 2021, moving from fifth to fourth among comparator countries.
Commercial research associated with the clinical research network generated £1.8 billion in gross value added to the UK economy in 2018 to 2019.
Top London contract research companies
Provides contract research services for pharmaceutical and biotechnology companies, including early‑phase and Phase II–III clinical trials, human challenge studies for infectious diseases, clinical…
Serves pharmaceutical, biotechnology and vaccine developers, including sponsors of early-phase to Phase III clinical trials. Targets organisations needing human challenge studies, respiratory and…
Location
Provides contract research services for pharmaceutical and biotechnology companies, including early‑phase and Phase II–III clinical trials, human challenge studies for infectious diseases, laboratory…
Serves pharmaceutical, biotech and vaccine developers, plus clinical trial sponsors working on infectious, respiratory, cardiometabolic, renal and hepatic disease programmes.
Location
HAMMERSMITH MEDICINES RESEARCH LIMITED
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsProvides clinical research services for pharmaceutical and biotechnology companies, specialising in Phase 1 and early Phase 2 trials. Offers study design, regulatory support, volunteer recruitment,…
Serves pharmaceutical and biotechnology companies worldwide, including drug developers of all sizes needing outsourced early-stage clinical trial support.
Financial Health
StableStable · 0% CAGR over 2y
Location
Provides contract research and biopharmaceutical development services, including design and management of Phase I–IV clinical trials, regulatory strategy and submissions, market access consulting,…
Serves biotech, pharmaceutical and biopharmaceutical companies, including clinical development, regulatory, market access and medical affairs teams managing drug development from early phase trials…
Location
VERISTAT INTERNATIONAL LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsProvides contract research and consulting services for pharmaceutical and biotechnology companies, including clinical trial design and management, regulatory strategy and submissions, data…
Serves pharmaceutical, biopharmaceutical, biotech, and medical device/IVD companies developing complex or novel therapies, especially clinical development, regulatory affairs, and R&D teams.
Financial Health
DistressedDistressed · -7% CAGR over 2y
Location
OPIS ON PHARMACEUTICAL INDUSTRY SERVICE UK LTD
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsProvides contract research organisation services for pharmaceutical, biotechnology and medical device companies, including clinical trial design and management, regulatory support, data management,…
Serves international pharmaceutical, biotechnology, medical device and nutraceutical companies sponsoring clinical studies, including teams running multi-country interventional and non-interventional…
Financial Health
StrongStrong · Hiring · 12% CAGR over 4y
Location
RESEARCH ORGANISATION (KC) LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides clinical research services including design, management and monitoring of multi-centre clinical trials. Offers project management, feasibility and trial design, clinical informatics, quality…
Serves pharmaceutical, academic and biotechnology organisations running pan-European clinical trials, especially late-phase and post-marketing studies in HIV, hepatitis, Covid-19 and infectious…
Financial Health
HealthyHealthy · Profitable, Hiring · 9% CAGR over 4y
Location
Lambda Therapeutic Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsProvides contract research services for pharmaceutical and biotechnology companies, including clinical trial management (Phase I–IV), regulatory affairs, biostatistics and data management,…
Serves biotech and pharmaceutical companies, including clinical development, regulatory, medical affairs and pharmacovigilance teams managing early-stage through Phase II-IV therapy programmes across…
Financial Health
HealthyHealthy · 0% CAGR over 2y
Location
ST. Pancras Clinical Research
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsConducts clinical research and runs clinical trials focused on Alzheimer’s disease, chronic pain conditions and diabetes. Recruits and manages study participants and works with pharmaceutical or…
Serves corporate clinical trial sponsors and research participants involved in Alzheimer’s disease, chronic pain and diabetes studies.
Financial Health
HealthyHealthy · Hiring · 4% CAGR over 4y
Location
Pharmalys Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides contract research services for clinical studies, including trial design and management, clinical monitoring, regulatory affairs, medical safety, data management and biostatistics. Also…
Serves life sciences and global health organisations running human health research, including clinical trial sponsors across Europe and Sub-Saharan Africa, plus clinical research professionals and…
Financial Health
StableStable · Hiring · 48% CAGR over 4y
Location
AVILLION LIFE SCIENCES LTD
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsProvides clinical development services for pharmaceutical and biotechnology companies, including end-to-end management of global clinical trials, regulatory strategy and submissions, site oversight,…
Serves pharmaceutical and biotech companies, particularly R&D and clinical development teams running global drug development programmes across North America, Europe and Asia.
Financial Health
StrongStrong
Location
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsProvides clinical research organization services for biotech and pharmaceutical companies, including clinical trial management, regulatory and pharmacovigilance consulting, data management,…
Serves emerging biotech and pharmaceutical companies developing therapies, including clinical development, regulatory, pharmacovigilance and drug development teams running global trials across…
Financial Health
StrongStrong · Hiring · 32% CAGR over 4y
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsProvides contract research services for ophthalmology product development, including clinical trial management, site monitoring, regulatory support, data management, and biostatistics. Supports Phase…
Serves ophthalmic pharmaceutical, biotech and medical device innovators, especially trial sponsors developing eye-care products and seeking European clinical research coverage.
Financial Health
HealthyHealthy · Hiring · 6% CAGR over 2y
Location
Trajectory
4y · 2023–NowFinancial sub-scores
Computed from 4 filingsProvides contract research services for biotechnology and pharmaceutical companies, supporting clinical development from Phase I–III trials to post‑authorisation and real‑world evidence studies, and…
Serves biotechnology and pharmaceutical companies, particularly clinical development and outsourcing teams running Phase I–IV studies across dermatology, internal medicine, neuroscience, oncology and…
Financial Health
WeakWeak · -6% CAGR over 3y
Location
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsOperates a contract research organisation supporting clinical trials through a global network of research sites. Provides a digital platform for collaboration between sponsors, CRO teams and sites,…
Sells to pharmaceutical sponsors, CROs and clinical research organisations running clinical studies, and also serves research sites joining its global network. Targets teams managing international…
Financial Health
StrongStrong · Hiring · 18% CAGR over 3y
Location
Provides contract research and biopharmaceutical development services to pharmaceutical and biotechnology companies, including Phase I–IV clinical trial management, regulatory strategy and…
Serves pharmaceutical, biotechnology and biopharmaceutical companies, targeting clinical development, regulatory, market access and medical affairs teams involved in drug development and…
Location
Image Analysis Limited
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsProvides imaging contract research services for clinical trials, including centralized imaging data management, radiological image review, and AI‑based analysis via the DYNAMIKA platform to support…
Serves pharmaceutical, biotech and medical device sponsors running global clinical trials, plus research teams needing imaging endpoints across musculoskeletal, oncology, metabolic, autoimmune, rare…
Financial Health
DistressedDistressed · Hiring · 14% CAGR over 1y
Location
PROPHARMA-UK LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides consulting and outsourced services to pharmaceutical, biotechnology and medical device companies, including regulatory affairs, clinical research support, pharmacovigilance, medical…
Serves pharmaceutical, biotechnology, medical device, cell and gene therapy, and animal health companies, including teams responsible for regulatory affairs, clinical development, pharmacovigilance,…
Financial Health
HealthyHealthy · -11% CAGR over 4y
Location
Icon
Trajectory
5y · 2020–NowProvides outsourced clinical research and development services for pharmaceutical, biotechnology and medical device companies, including clinical trial management, early‑phase laboratory services,…
Serves pharmaceutical, biotechnology and medical device companies, plus government and public health organisations, seeking outsourced clinical development, consulting and commercialisation support.
Financial Health
Insufficient historyInsufficient history
Location
ADNOVATE CLINICAL DEVELOPMENT STRATEGIES LTD
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsProvides clinical development consulting to life sciences and biotechnology companies, including drug development strategy, asset development planning, regulatory strategy, and management and…
Serves B2B life science companies, particularly biotech and pharma firms developing drug assets through pre-clinical, clinical, regulatory and commercialization stages across multiple therapeutic…
Financial Health
StrongStrong · Growing · 0% CAGR over 4y
Location
Cytel Statistical Services And Software UK Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides statistical consulting, clinical trial design, and data analytics software for biopharmaceutical, medical device, academic, and government researchers. Offers trial design tools, data…
Serves life sciences trial sponsors, including biopharmaceutical and medical device companies, academic research groups and government research bodies involved in drug development, clinical trials,…
Financial Health
StableStable · Hiring · 30% CAGR over 4y
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsProvides clinical trial support services and technology, including clinical operations, site support, data management, biostatistics, and medical writing. Also delivers drug safety and…
Serves pharmaceutical, biotech and medical research organisations running clinical trials, plus clinical sites and institutions needing IRB, biosafety and pharmacovigilance support.
Financial Health
HealthyHealthy · Hiring · 123% CAGR over 2y
Location
STARK PHARMACEUTICALS LIMITED
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsProvides pharmaceutical and medical device development services including clinical research, regulatory affairs, biostatistics and drug safety. Also delivers healthcare IT solutions such as cloud,…
Sells to businesses in life sciences and healthcare, including pharmaceutical, biotechnology, medical device, consumer health and cosmetics organisations. Serves teams needing CRO, regulatory,…
Financial Health
StrongStrong
Location
SPECIALIST BIOANALYTICAL SERVICES LIMITED
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsProvides contract bioanalytical laboratory services for pharmaceutical and biotechnology drug development, including preclinical and clinical sample analysis, toxicokinetics studies, biomarker and…
Serves pharmaceutical, biotechnology and contract research organisations running drug development programmes, from discovery through pre-clinical safety testing and clinical development, including…
Financial Health
StableStable · 0% CAGR over 3y
Location
The Medical Department Ltd
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsProvides medical consultancy services to pharmaceutical and life sciences companies, including medical affairs support, regulatory and code compliance, pharmacovigilance, clinical development…
Serves pharmaceutical and life sciences organisations with global operations, including teams responsible for medical affairs, regulatory compliance, pharmacovigilance, market access, clinical…
Financial Health
StrongStrong · Hiring · 24% CAGR over 3y
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
StableStable · -71% CAGR over 4y
Location
Vitalograph
Develops and manufactures respiratory diagnostic devices and software, including spirometers, pulmonary function testing systems, monitoring tools, and bacterial/viral filters. Also provides…
Serves B2B healthcare organisations, occupational health providers, medical researchers, and pharmaceutical or biotech clinical trial teams worldwide, especially those focused on respiratory…
Location
Koneksa Health
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsDevelops digital biomarker technologies and software for clinical trials, using connected devices and remote data collection to measure patient outcomes. Provides data engineering, analytics, and…
Serves pharmaceutical and biotech clinical trial sponsors, clinical operations teams and researchers developing therapies in neuroscience, including Parkinson’s, MS and rare disease programmes.
Financial Health
StrongStrong · Hiring · 48% CAGR over 5y
Location
Unlock all 26 leads
Showing 28 of 26 — +0 more with verified decision-maker contacts, live data, and CRM sync.
How London contract research companies work and how to sell to them
What they do
Revenue usually comes from project fees, time-and-materials work, fixed-price deliverables and longer managed-service retainers. London contract research providers sell regulated labour and know-how rather than a repeatable licence: protocol writing, site monitoring, data management, statistical analysis, medical writing and study close-out all create billable work. Larger assignments often include pass-through costs for investigators, labs or technology platforms, with change-control clauses when protocols, timelines or recruitment assumptions shift. Pricing therefore depends on scope, risk transfer and the seniority of staff assigned. Margin discipline matters because sponsors expect documentation, quality review and audit support to be included, not treated as optional extras.
Who they sell to
Most buyers are life-sciences sponsors, specialist development teams and investigator-led groups that need external capacity without losing sponsor oversight. The first conversation may sit with a clinical operations director, chief medical officer, head of biometrics, regulatory lead or quality lead; procurement often arrives once the scientific and operational fit has been tested. Typical sales cycles are consultative and can run through capability calls, confidentiality agreements, budget grids, quality questionnaires and preferred-supplier reviews. Higher-value work is often sourced through RFPs or existing sponsor networks, while smaller protocol, statistics or writing assignments can be won through senior relationships and evidence of relevant therapeutic experience.
What they buy
Most contract research firms tend to spend on systems and services that protect trial quality, delivery capacity and bid competitiveness. Common categories include clinical trial management software, electronic trial-master-file tools, quality management systems, document control, validated cloud hosting, security monitoring, data management platforms, statistical programming support and safety-reporting workflows. They also buy professional services around legal contracting, insurance, finance, tax, recruitment, training, marketing collateral and bid support. Hiring can be difficult where experienced monitors, statisticians, medical writers or quality staff are needed at short notice, so recruitment partners and specialist contractors often become part of the operating model rather than occasional suppliers.
Why and how to sell to them
Contract research buyers tend to evaluate vendors when a new sponsor programme is won, a preferred-supplier review starts, senior quality or operations leadership changes, headcount rises, or an MHRA inspection exposes gaps in oversight evidence. Fixed-price projects also create buying pressure when manual work, rework or document reconciliation starts to erode margins. Outbound angles work better when they refer to trial delivery constraints rather than generic productivity: audit trails, faster study set-up, cleaner handovers, fewer overdue actions, clearer sponsor reporting and easier quality review. Claims need proof, because these firms sell assurance as much as capacity.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Also in London
Related directories
Frequently asked questions
How many contract research companies are there in the London?↓
What counts as a contract research company in this list?↓
Which are the largest contract research companies in the London?↓
What do contract research companies in the London actually do?↓
How does London contract research compare internationally?↓
How is this list built and how fresh is the data?↓
How big are the typical contract research companies in the London?↓
Are these mostly new or established contract research companies?↓
What SIC codes does this use?↓
What buying signals should I look for?↓
Push these 26 companies into your pipeline.
Find the right decision-makers, see verified company data, and export your list in seconds.